%PDF-1.6
%
1 0 obj
<<
/Lang (en)
/MarkInfo <<
/Marked true
>>
/Metadata 2 0 R
/Outlines 3 0 R
/PageLayout /OneColumn
/PageMode /UseOutlines
/Pages 4 0 R
/StructTreeRoot 5 0 R
/Type /Catalog
/ViewerPreferences <<
/DisplayDocTitle true
>>
>>
endobj
6 0 obj
<<
/Author (Gemeinsamer Bundesausschuss/Federal Joint Committee \(g-ba.de\))
/Category (Nr. XXX \(S. XX XXX\))
/Comments (Anlage XY zu TOP XY)
/Company (Gemeinsamer Bundesausschuss, \(www.g-ba.de\))
/CreationDate (D:20220819101450+02'00')
/Creator <4163726F626174205044464D616B65722032302066FC7220576F7264>
/Keywords <416E6E65782058494920852042656E65666974204173736573736D656E74206F66204D65646963696E616C2050726F64756374732077697468204E65772041637469766520496E6772656469656E7473206163636F7264696E6720746F2053656374696F6E203335612053474220560D0A4175746F6C6F676F757320416E74692D43442D31392D7472616E736475636564204344332B2043656C6C73202872656C6170736564206F7220726566726163746F7279206D616E746C652063656C6C206C796D70686F6D61293B0D0A5265737472696374696F6E206F662074686520417574686F7269747920746F20537570706C792043617265>
/ModDate (D:20220819112008+02'00')
/Producer (Adobe PDF Library 20.5.173)
/SourceModified (D:20220819062549)
/Subject (Pharmaceuticals Directive \(AM-RL\):)
/Title (Justification)
>>
endobj
2 0 obj
<<
/Length 5133
/Subtype /XML
/Type /Metadata
>>
stream
2022-08-19T11:20:08+02:00
2022-08-19T10:14:50+02:00
2022-08-19T11:20:08+02:00
Acrobat PDFMaker 20 für Word
uuid:b698bb0d-edd1-4af4-b129-98ff9f4b7a78
uuid:44f34281-f5d5-4b15-b6fe-6fc17b64d46c
2
application/pdf
Justification
Pharmaceuticals Directive (AM-RL):
Gemeinsamer Bundesausschuss/Federal Joint Committee (g-ba.de)
Annex XII – Benefit Assessment of Medicinal Products with New Active Ingredients according to Section 35a SGB V
Autologous Anti-CD-19-transduced CD3+ Cells (relapsed or refractory mantle cell lymphoma)
Restriction of the Authority to Supply Care
Adobe PDF Library 20.5.173
Annex XII – Benefit Assessment of Medicinal Products with New Active Ingredients according to Section 35a SGB V
Autologous Anti-CD-19-transduced CD3+ Cells (relapsed or refractory mantle cell lymphoma);
Restriction of the Authority to Supply Care
D:20220819062549
Gemeinsamer Bundesausschuss, (www.g-ba.de)
Anlage XY zu TOP XY
Nr. XXX (S. XX XXX)
Arzneimittel-Richtlinie (AM-RL):
endstream
endobj
3 0 obj
<<
/Count 7
/First 7 0 R
/Last 8 0 R
/Type /Outlines
>>
endobj
4 0 obj
<<
/Count 4
/Kids [9 0 R 10 0 R 11 0 R 12 0 R]
/Type /Pages
>>
endobj
5 0 obj
<<
/K 13 0 R
/ParentTree 14 0 R
/ParentTreeNextKey 8
/RoleMap 15 0 R
/Type /StructTreeRoot
>>
endobj
7 0 obj
<<
/A 16 0 R
/Count 2
/First 17 0 R
/Last 18 0 R
/Next 19 0 R
/Parent 3 0 R
/Title (Justification)
>>
endobj
8 0 obj
<<
/A 20 0 R
/Parent 3 0 R
/Prev 21 0 R
/Title (4. Process sequence)
>>
endobj
9 0 obj
<<
/Annots [22 0 R 23 0 R 24 0 R 25 0 R]
/Contents [26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/Font <<
/TT0 35 0 R
/TT1 36 0 R
>>
/XObject <<
/OL1 37 0 R
>>
>>
/Rotate 0
/StructParents 0
/Tabs /S
/Type /Page
>>
endobj
10 0 obj
<<
/Contents [38 0 R 39 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/Font <<
/TT0 35 0 R
/TT1 36 0 R
/TT2 40 0 R
>>
/XObject <<
/OL1 37 0 R
>>
>>
/Rotate 0
/StructParents 5
/Tabs /S
/Type /Page
>>
endobj
11 0 obj
<<
/Contents [41 0 R 42 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/Font <<
/TT0 35 0 R
/TT1 36 0 R
/TT2 40 0 R
>>
/XObject <<
/OL1 37 0 R
>>
>>
/Rotate 0
/StructParents 6
/Tabs /S
/Type /Page
>>
endobj
12 0 obj
<<
/Contents [43 0 R 44 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/Font <<
/TT0 35 0 R
/TT1 36 0 R
>>
/XObject <<
/OL1 37 0 R
>>
>>
/Rotate 0
/StructParents 7
/Tabs /S
/Type /Page
>>
endobj
13 0 obj
<<
/K [45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R
55 0 R 56 0 R 57 0 R 58 0 R 59 0 R 60 0 R 61 0 R 62 0 R 63 0 R 64 0 R
65 0 R 66 0 R 67 0 R 68 0 R 69 0 R 70 0 R 71 0 R 72 0 R 73 0 R 74 0 R
75 0 R 76 0 R]
/P 5 0 R
/S /Sect
>>
endobj
14 0 obj
<<
/Nums [0 [45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R null 77 0 R null null
78 0 R 79 0 R null null 80 0 R 81 0 R null null 82 0 R 83 0 R
null null 84 0 R 85 0 R null 86 0 R null]
1 78 0 R 2 80 0 R 3 82 0 R 4 84 0 R
5 [52 0 R 53 0 R 54 0 R 55 0 R 56 0 R 57 0 R 58 0 R]
6 [59 0 R 60 0 R 61 0 R 62 0 R 63 0 R 64 0 R 65 0 R 66 0 R 67 0 R 68 0 R
69 0 R]
7 [70 0 R 71 0 R 73 0 R 74 0 R 75 0 R 76 0 R null 87 0 R null 88 0 R
null null 89 0 R null 90 0 R null null 91 0 R null 92 0 R
null 93 0 R null 94 0 R null 95 0 R 96 0 R 97 0 R null 98 0 R
null 99 0 R null 100 0 R 101 0 R 102 0 R 103 0 R 104 0 R null 105 0 R
null 106 0 R 107 0 R 108 0 R null 109 0 R null 110 0 R null 111 0 R
112 0 R 113 0 R null 114 0 R null 115 0 R 116 0 R 117 0 R null 118 0 R
null 119 0 R null 120 0 R 121 0 R 122 0 R null 123 0 R null 124 0 R
125 0 R 126 0 R]
]
>>
endobj
15 0 obj
<<
/Annotation /Span
/Artifact /P
/Bibliography /BibEntry
/Chart /Figure
/Diagram /Figure
/DropCap /Figure
/Endnote /Note
/Footnote /Note
/InlineShape /Figure
/Outline /Span
/Strikeout /Span
/Subscript /Span
/Superscript /Span
/TextBox /Art
/Underline /Span
>>
endobj
16 0 obj
<<
/D [9 0 R /XYZ 69 743 0.0]
/S /GoTo
>>
endobj
17 0 obj
<<
/A 127 0 R
/Next 18 0 R
/Parent 7 0 R
/Title (of the Resolution of the Federal Joint Committee \(G-BA\) on the Amendment of the Pharmaceuticals Directive \(AM-RL\):)
>>
endobj
18 0 obj
<<
/A 128 0 R
/Parent 7 0 R
/Prev 17 0 R
/Title <416E6E65782058494920852042656E65666974204173736573736D656E74206F66204D65646963696E616C2050726F64756374732077697468204E65772041637469766520496E6772656469656E7473206163636F7264696E6720746F2053656374696F6E20333561205347422056>
>>
endobj
19 0 obj
<<
/A 129 0 R
/Next 130 0 R
/Parent 3 0 R
/Prev 7 0 R
/Title (1. Legal basis)
>>
endobj
20 0 obj
<<
/D [11 0 R /XYZ 69 440 0.0]
/S /GoTo
>>
endobj
21 0 obj
<<
/A 131 0 R
/Next 8 0 R
/Parent 3 0 R
/Prev 130 0 R
/Title (3. Bureaucratic costs calculation)
>>
endobj
22 0 obj
<<
/A 132 0 R
/BS <<
/S /S
/Type /Border
/W 0
>>
/Border [0 0 0]
/H /I
/Rect [68.6499 417.963 526.15 443.147]
/StructParent 1
/Subtype /Link
/Type /Annot
>>
endobj
23 0 obj
<<
/A 133 0 R
/BS <<
/S /S
/Type /Border
/W 0
>>
/Border [0 0 0]
/H /I
/Rect [68.6499 392.779 526.15 417.963]
/StructParent 2
/Subtype /Link
/Type /Annot
>>
endobj
24 0 obj
<<
/A 134 0 R
/BS <<
/S /S
/Type /Border
/W 0
>>
/Border [0 0 0]
/H /I
/Rect [68.6499 367.596 526.15 392.779]
/StructParent 3
/Subtype /Link
/Type /Annot
>>
endobj
25 0 obj
<<
/A 135 0 R
/BS <<
/S /S
/Type /Border
/W 0
>>
/Border [0 0 0]
/H /I
/Rect [68.6499 342.412 526.15 367.596]
/StructParent 4
/Subtype /Link
/Type /Annot
>>
endobj
26 0 obj
<<
/Length 37
/Filter /FlateDecode
>>
stream
x+*23P0bdBr.KB W
endstream
endobj
27 0 obj
<<
/Length 784
/Filter /FlateDecode
>>
stream
HUn0+H"%J@ i=6hdc
GNN{lh0b>D!b[t12^kr HEآI,7M̐_tHt}3
N
,2aU!M fs